1,069
Views
18
CrossRef citations to date
0
Altmetric
Original Article

Randomized, double blind trial of Zolpidem 10 mg versus triazolam 0.25 mg for treatment of insomnia in general practice

Pages 88-92 | Received 01 Mar 1993, Accepted 01 Sep 1993, Published online: 12 Jul 2009

References

  • Perry P J., Smith D A. Triazolam — the never-ending story. DICP 1991; 25: 1263–4
  • Pakes G E., Brogden R N., Heel R C., Speight T M., Avery G S. Triazolam: a review of its pharmacological properties and therapeutic efficacy in patients with insomnia. Drugs 1981; 22: 81–110
  • Langtry H D., Benfield P. Zolpidem: a review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential. Drugs 1990; 40: 291–313
  • Louvel E, Cramer P, Ferreri M, Pagot R, Régnier F, L'Héritier C L., . Zolpidem and triazolam: long-term multicenter studies (1–3 months) in psychiatric and general practice patients. Imidazopyridines in sleep disorders, J P. Sauvanet, S Z. Langer, P L. Morselli, et al. Raven Press, New York 1988; 327–37
  • Aitken R CB. Measurement of feelings using visual analogue scales. Proc Roy Soc Med 1969; 62: 989–93
  • Closs S J. Assessment of sleep in hospital patients: a review of methods. J Adv Nurs 1988; 13: 501–10
  • Miller N S., Gold M S. Benzodiazepines: tolerance, dependence, abuse, and addiction. J Psychoactive Drug 1990; 22: 23–33
  • Kales A, Scharf M B., Kales J D., Soldates C R. Rebound insomnia: a potential hazard following withdrawal of certain benzodiazepines. JAMA 1979; 241: 1692–5
  • Gillin J C., Spinweber C L., Johnson L C. Rebound insomnia: a critical review. J Clin Psychopharmacol 1989; 9: 161–72
  • Evans S M., Funderburk F R., Griffiths R R. Zolpidem and triazolam in humans: behavioral and subjective effects and abuse liability. J Pharmacol Exp Ther 1990; 255: 1246–55
  • Surendrakumar D, Dunn M, Roberts C JC. Hospital admission and the start of benzodiazepine use. BMJ 1992; 304: 881
  • Schlich D, L'Heritier C, Coquelin J P., Attali P. Long-term treatment of insomnia with Zolpidem: a multicentre general practitioner study of 107 patients. J Int Med Res 1991; 19: 271–9
  • Monti J M. Effect of Zolpidem on sleep in insomniac patients. Eur J Clin Pharmacol 1989; 36: 461–6
  • Herrmann W M., Kubicki S, Wober W. Zolpidem: a four-week pilot polysomnographic study in patients with chronic sleep disturbances. Imidazopyridines in sleep disorders, J P. Sauvanet, S Z. Langer, P L. Morselli. Raven Press, New York 1988; 261–78
  • Terzano M G., Parrino L. Evaluation of EEG cyclic alternating pattern during sleep in insomniacs and controls under placebo and acute treatment with Zolpidem. Sleep 1992; 15: 64–70
  • Kryger M H., Steljes D, Pouliot Z, Neufeld H, Odynski T. Subjective versus objective evaluation of hypnotic efficacy: experience with Zolpidem. Sleep 1991; 14: 399–407
  • Belyavin A, Nicholson A N. Rapid eye movement sleep in man: modulation by benzodiazepines. Neuropharmacology 1987; 26: 485–91
  • Borenstein P, Cujo P. Influence of barbiturates and benzodiazepines on the sleep EEG. Mod Probl Pharmacopsychiatr 1974; 8: 182–92
  • Bixler E O., Kales A, Manfredi R L., Vgontzas A N., Tyson K L., Kales J D. Next-day memory impairment with triazolam use. Lancet 1991; 337: 827–31
  • Dyer C. UK licensing authority continues Halcion ban. BMJ 1992; 305: 332–3

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.